Beta-Hydroxybutyrate Feasibility Treating IBD

Clinical trial NCT06351124 · RECRUITING

Trial details

NCT number: NCT06351124
Sponsor: University of Texas at Austin
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Crohn's Disease Inflammatory Bowel Diseases

Start date: 2024-08-28
Primary completion: 2025-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.